Abstract. Fibronectin matrix assembly is a cell-dependent process which is upregulated in tissues at various times during development and wound repair to support the functions of cell adhesion, migration, and differentiation. Previous studies have demonstrated that the ot5131 integrin and fibronectin's amino terminus and III-1 module are important in fibronectin polymerization. We have recently shown that fibronectin's III-1 module contains a conformationally sensitive binding site for fibronectin's amino terminus (Hocking, D.C., J. Sottile, and P.J. McKeown-Longo. 1994. J. Biol. Chem. 269: 19183-19191). The present study was undertaken to define the relationship between the ot5131 integrin and fibronectin polymerization. Solid phase binding assays using recombinant III-10 and II1-1 modules of human plasma fibronectin indicated that the III-10 module contains a conformation-dependent binding site for the III-1 module of fibronectin. Unfolded III-10 could support the formation of a ternary complex containing both III-1 and the amino-terminal 70-kD fragment, suggesting that the III-1 module can support the simultaneous binding of III-10 and 70 kD. Both unfolded III-10 and unfolded III-1 could support fibronectin binding, but only III-10 could promote the formation of disulfide-bonded multimers of fibronectin in the absence of cells. III-10-dependent multimer formation was inhibited by both the anti-III-1 monoclonal antibody, 9D2, and amino-terminal fragments of fibronectin. A fragment of III-10, termed III-10/A, was able to block matrix assembly in fibroblast monolayers. Similar resuits were obtained using the III-10A/RGE fragment, in which the RGD site had been mutated to RGE, indicating that III-10/A was blocking matrix assembly by a mechanism distinct from disruption of integrin binding. Texas red-conjugated recombinant 111-1,2 localized to [31-containing sites of focal adhesions on cells plated on fibronectin or the III-9,10 modules of fibronectin. Monoclonal antibodies against the III-1 or the 11I-9,10 modules of fibronectin blocked binding of III-1,2 to cells without disrupting focal adhesions. These data suggest that a role of the tXs~ 1 integrin in matrix assembly is to regulate a series of sequential self-interactions which result in the polymerization of fibronectin.
Abstract. Fibronectin matrix assembly is a cell-dependent process which is upregulated in tissues at various times during development and wound repair to support the functions of cell adhesion, migration, and differentiation. Previous studies have demonstrated that the ot5131 integrin and fibronectin's amino terminus and III-1 module are important in fibronectin polymerization. We have recently shown that fibronectin's III-1 module contains a conformationally sensitive binding site for fibronectin's amino terminus (Hocking, D.C., J. Sottile, and P.J. McKeown-Longo. 1994 . J. Biol. Chem. 269: 19183-19191 ). The present study was undertaken to define the relationship between the ot5131 integrin and fibronectin polymerization. Solid phase binding assays using recombinant III-10 and II1-1 modules of human plasma fibronectin indicated that the III-10 module contains a conformation-dependent binding site for the III-1 module of fibronectin. Unfolded III-10 could support the formation of a ternary complex containing both III-1 and the amino-terminal 70-kD fragment, suggesting that the III-1 module can support the simultaneous binding of III-10 and 70 kD. Both unfolded III-10 and unfolded III-1 could support fibronectin binding, but only III-10 could promote the formation of disulfide-bonded multimers of fibronectin in the absence of cells. III-10-dependent multimer formation was inhibited by both the anti-III-1 monoclonal antibody, 9D2, and amino-terminal fragments of fibronectin. A fragment of III-10, termed III-10/A, was able to block matrix assembly in fibroblast monolayers. Similar resuits were obtained using the III-10A/RGE fragment, in which the RGD site had been mutated to RGE, indicating that III-10/A was blocking matrix assembly by a mechanism distinct from disruption of integrin binding. Texas red-conjugated recombinant 111-1,2 localized to [31-containing sites of focal adhesions on cells plated on fibronectin or the III-9,10 modules of fibronectin. Monoclonal antibodies against the III-1 or the 11I-9,10 modules of fibronectin blocked binding of III-1,2 to cells without disrupting focal adhesions. These data suggest that a role of the tXs~ 1 integrin in matrix assembly is to regulate a series of sequential self-interactions which result in the polymerization of fibronectin.
F
IBRONECTINS are a family of high molecular weight, multidomain glycoproteins composed of two structurally similar subunits which are joined at the carboxyl terminus by disulfide bonds (17) . Fibronectin, like many other proteins of the extraceUular matrix, is a mosaic protein composed of modular units (17) . The primary structure of fibronectin is organized into three types of repeating homologous units, termed types I, II, and III (17, 30) . These modules in turn are organized into functional domains which have been shown to contain multiple binding sites, including those for sulfated glycosaminoglycans, gelatin, fibrin, and cell surface integrin receptors (26, 30, 51 Fibronectin is secreted as a dimer into the blood and other body fluids, where it circulates at micromolar concentrations as a soluble, protomeric molecule. In addition, an insoluble, multimeric form of fibronectin is found within the extracellular spaces of connective tissue, basement membranes, and cultured cells (17) . This multimeric form of fibronectin is its primary functional form, mediating a variety of adhesive and migratory events during embryogenesis, angiogenesis, thrombosis and hemostasis, inflammation, and wound repair (17) .
Polymerization of soluble fibronectin into insoluble fibrils is a dynamic, multistep, cell-dependent process which occurs at the surface of substrate-attached cells (28) . The mechanism by which a fibronectin matrix is assembled, however, is only partially understood. In one of the initial steps of matrix assembly, cell surfaces bind the amino-terminal region of fibronectin in a reversible and saturable manner (22, 35) . Subsequent homophilic-binding interac-tions are thought to lead to the formation of disulfide-stabilized high molecular mass multimers (5, 24, 25) . The molecule(s) which mediates the initial binding of the amino terminus of fibronectin to cell surfaces has not been identified. These amino-terminal binding sites, termed matrix assembly sites (22) , have been defined operationally by ligand binding assays using t25I-labeled amino-terminal fragments of fibronectin (22, 35) . The expression of these binding sites on cell surfaces has been shown to be regulated by the a5131 integrin receptor for fibronectin (9) . Cellular adhesion to fibronectin is mediated primarily by the ~5131 integrin, which binds to fibronectin via the Arg-Gly-Asp sequence contained within the III-10 module (16, 32) . The importance of the c~5131 integrin receptor for fibronectin in the assembly of a fibronectin matrix has been demonstrated in several studies. Overexpression of the a5131 integrin in Chinese hamster ovary (CHO) cells results in an increase in the level of fibronectin deposition by these cells (11) . Transfection of the t~ 5 subunit into mutant CHO cells deficient in ct 5 expression restores the ability of these ceils to assemble a fibronectin matrix (48) . Antibodies directed against either a5131 (2) or the integrin-binding site in the 111-10 module of fibronectin (20) inhibit fibronectin fibril formation. In addition, anti-131 integrin antibodies have been shown to inhibit binding of the aminoterminal 70-kD fragment to the cell surface, suggesting that the oL5131 integrin can regulate the expression of matrix assembly sites (9) .
We recently identified a conformation-dependent site within the III-1 module of fibronectin which binds to the amino-terminal region of fibronectin with high affinity (15) . Based on these and other studies, we proposed a model in which the fibronectin molecule, bound to the integrin, undergoes conformational changes resulting in the exposure of the 70-kD binding site in III-1. These series of interactions form a "nucleation site" which serves as a template for the subsequent binding and incorporation of incoming fibronectin molecules into the extracellular matrix. The present study was undertaken to identify a mechanism by which the cryptic 70-kD binding site in III-1 may be exposed in the intact fibronectin molecule. We postulated that regulation of the conformation of the 70-kD binding site in III-1 by the a5131 integrin may be mediated by an interaction between fibronectin's integrin-binding III-10 module and the 70-kD-binding 111-1 module. In this study, we have used recombinant fibronectin modules to characterize a conformation-dependent binding site in the III-10 module of fibronectin which binds to III-1. The interaction of III-1 in intact fibronectin with III-10 promotes the formation of disulfide-stabilized high molecular mass multimers in the absence of cells, via an interaction involving the amino-terminal region of fibronectin. A fragment of III-10 which blocks the formation of in vitro fibronectin multimers also inhibits fibronectin polymerization by cells. In addition, we examined the expression of III-1 binding sites on cell surfaces and found that exogenously added 111-1,2 localizes at regions of focal adhesions and that localization to focal adhesions is dependent on the III-10 module. Taken together, these data suggest that Ot51~ 1 integrin regulation of fibronectin matrix assembly may be mediated, in part, by an interaction between the III-1 and III-10 modules of fibronectin.
Materials and Methods

Reagents
Materials for autoradiography were from Kodak (Rochester, NY). Gel electrophoresis supplies were from BioRad Labs (Richmond, VA). Unless otherwise indicated, chemical reagents were obtained from Sigma Chem. Co. (St. Louis, MO).
Cell Culture
Human foreskin fibroblasts, A1-F, were a gift from Dr. Lynn Allen-Hoffmann (University of Wisconsin, Madison, WI). A1-Fs were cultured in Dulbecco's modified Eagle's medium (DMEM) (GIBCO-BRL, Gaithersburg, MD) supplemented with 10% FBS (Sterile Systems, Logan, UT). 9D2 hybridoma cells (5) were a gift from Dr. Deane Mosher (University of Wisconsin, Madison, WI). Hybridoma cells were cultured in DMEM containing 20% heat-inactivated FBS.
Gel Electrophoresis
SDS-PAGE was performed according to Laemmli (19) using a discontinuous buffer system (BioRad Labs). Samples were diluted 1:1 in gel buffer containing 4% SDS and 20% glycerin in 0.05 M Tris, pH 6.8. Some samples were reduced with 2% 13-mercaptoethanol before electrophoresis. Proteins were visualized with 0.1% Coomassie blue (47) . Iodinated proteins were visualized by autoradiography. III-10 preparations were characterized on 16.5% polyacrylamide gels containing 13% glycerol, using a discontinuous tricine-SDS-PAGE system, according to the method of Sh~igger and von Jagow (39) . Proteins were visualized with 0.025% Serva blue G (Serva, Paramus, N J).
Purification of Fibronectin and Fibronectin Fragments
Human plasma fibronectin was purified from a fibronectin-and fibrinogen-rich by-product of Factor VIII production by ion exhange chromatography on DEAE-cellulose (Pharmacia LKB Biotechnology, Piscataway, NJ), as previously described (22) . Fig. 1 shows a schematic of the various fragments used in this study. The 70-kD amino-terminal fragment of fibronectin was generated by limited digestion of intact fibronectin with cathepsin D, followed by gelatin affinity chromatography, as previously described (22) . The 70-kD fragment was further cleaved into a 27-kD amino-terminal fragment and a 40-kD gelatin-binding fragment by limited digestion with trypsin (4). The 27-and 40-kD fragments were then separated by gelatin affinity chromatography. A preparation containing the 160/180-kD cell-and gelatin-binding fragments was generated by limited digestion of fibronectin with trypsin, and then isolated by retention on gelatin-Sepharose, as previously described (22) . Purity of all fragments was assessed by SDS-PAGE and proteins were frozen at -80°C until use.
Preparation of Recombinant Fibronectin Modules
Recombinant III-1 and III-2 were expressed in BL21(DE3) bacteria as fusion proteins composed of glutathione-S-transferase (GST) 1 and either III-1 or III-2, as previously described (15) . To separate III-1 or III-2 from GST, fusion proteins were incubated with TPCK-trypsin-agarose beads (1 U/mg) for 30 min at 20°C. After incubation, the TPCK-trypsin-agarose beads were removed by centrifugation. III-1 was further purified by passing the digested material over a fast protein liquid chromatography (FPLC) SP-5PW column (Waters, Boston, MA), as previously described (15) . The III-2 digest was purified by passing the digest over an FPLC Protein-Pak Q 8HR column (Waters). III-2 was eluted with a salt gradient from 0.015 M NaCI, 20 mM phosphate, pH 7.0 to 0.25 M NaCl, 20 mM phosphate, pH 7.0. III-2 eluted from the column in one sharp peak and was the only protein detected by SDS-PAGE.
Polymerase chain reaction (PCR) was used to amplify human fibronectin cDNA encoding the first and second type III modules (III-1,2) of fibronectin (bases 1745 through 2347). This DNA encodes amino acids from Ser-578 through Thr-778. Bases are numbered from the A in the codon for the first amino acid of the mature protein (EMBL accession number X02761), and amino acids are numbered from the amino-terminal , and the I11-10 construct (5'-CCCGAATI'CCTATGTTCGGTAATTAATGGAAATTG) were synthesized with an EcoRI site (shown in bold) at the 5' end. The antisense primer for the Ill-9,10 construct (5'-CCCCCCGGGCTATGTTCGG-TAATTAATGGAAATTG) was synthesized with a SmaI site (shown in bold) at the 5' end. Underlined bases introduce a stop codon after the last base in the sequence to be amplified. The III-10/RGE mutant was produced using recombinant PCR (14) . The two mutant primers were 5'-CCG-TGGAGAAAGCCCCGCAAGC (sense primer) and 5'-GC'ITGCGGG-GCTITCTCCACGG (antisense primer). The mutated base is shown in bold. The two outer primers used were the same as those used to amplify nonmutant 111-10. PCR was performed according to established procedures (37), using human full-length fibronectin cDNA, pFH100 (a gift of Dr. Jean Thiery, Paris, France) as a template. After restriction enzyme digestion, the PCR amplified DNA was cloned into the bacterial expression vector pGEX-2T (Pharmacia). PCR amplified DNA was sequenced to confirm that no base changes had been introduced during amplification of the DNA and to establish the presence of the mutated base in III-10/RGE (38) , DNA encoding either 111-1,2, III-10, III-10/RGE, or 111-9,10 was cloned in frame with the bacterial glutathione-S-transferase DNA. DNA was transfected into BL21(DE3) bacteria using standard procedures (37) . Fusion proteins were isolated by passing bacterial lysates over glutathione agarose, as previously described (15) . Fusion proteins were then digested with l U/mg Tt'CK-trypsin-agarose for 30 min at 20°C. This cleavage gives rise to an additional glycine and serine residue at the amino terminus of the isolated modules. The Ill-5 and 111-1,2 constructs were isolated by passing the digested materal over an FPLC Protein-Pak Q 8HR column (Waters) and eluting with a salt gradient from 0.015 M NaCI, 20 mM phosphate, pH 7.0 to 0.25 M NaCI, 20 mM phosphate, pH 7.0. Amino acid sequencing of III-1,2 yielded the following amino terminal sequence: GSSGPVEVFI, corresponding to the region beginning at the amino-terminus of 1II-1, starting at Ser 578. 111-9,10 was isolated by passing the digested material over a glutathione agarose column. To isolate II1-10, the TPCK-trypsin--digested material was passed twice over a high performance liquid chromatography Protein-Pak 125 gel filtration column (Waters). For some studies, GST/III-10 and GST/III-10/RGE were digested with 0.5 U/mg trypsin-acrylic beads (non-TPCK-treated) for 30 min at 20°C (III-10A and III-10A/RGE) and purified as described for III-10. The apparent molecular masses of the 111-10 preparations were determined by tricine-SDS-PAGE and are as follows: III-10 = 17 kD, III-10A and III-10A/RGE = 14.5 kD. Amino acid sequencing of III-10, III-10A, and III-10A/RGE yielded identical amino-terminal sequences: GSVSDVPRDL. This sequence corresponds to the region beginning at the amino terminus of III-10, starting at Val-1415.
Preparation of 9D2 lgG and Fab' Fragments
Ascite~ of 9D2 were prepared as described (13) . Immunoglobulins (IgGs) were isolated by passing the ascites over a protein A-Sepharose CL-4B column (Pharmacia) equilibrated with 100 mM sodium phosphate (pH 7.0). Bound IgG was eluted with 1 M acetic acid, 100 mM glycine (pH 3.0). The eluate was neutralized to pH 7.4 with 1 M Tris (pH 10.0) and dialyzed against PBS. 9D2 IgG, diluted in 0.1 M sodium citrate buffer, pH 4, was digested with pepsin (1:200 wt/wt) for 15 h at 37°C to produce F(ab')2 fragments (13) . Monovalent Fab' fragments were obtained after reduction of F(ab')2 with 10 mM 13-mercaptoethanol for 2 h at 37°C and alkylation with 10 mM iodoacetamide for 4 h at 20°C (13) . Fab' fragments were dialyzed against PBS, and then passed over a protein A-Sepharose CL-4B column (Pharmacia) to remove intact IgG. Purity was assessed by SDS-PAGE and aliquots were stored at -80°C before use. Nonimmune mouse F(ab')2 fragments (Cappel, Durham, NC) were similarly reduced, alkylated, and dialyzed against PBS to produce Fab' fragments.
Iodination of Fibronectin and Fibronectin Fragments
For solid phase and cell binding assays, 27 and 70 kD, fibronectin, and III-1 and III-2 were iodinated with 1.0 mCi NalZSI (New England Nuclear, Boston, MA) using chloramine T, as previously described (22) . The iodination reaction was stopped with sodium metabisulfite (Fisher Scientific, Fair Lawn, N J) and free iodine was removed by chromatography on G-25M Sephadex (Pharmacia). Iodinated proteins were dialyzed against PBS and frozen at -80°C until use. Integrity of the labeled proteins was assessed by gel electrophoresis and autoradiography. Specific activities of labeled proteins ranged from 2.1-11.9 × 104 Ci/mol.
Solid Phase Binding Assay
Solid phase binding assays were performed essentially as described (15) . III-1, III-2, III-5, or III-10 was diluted to 10 ixg/ml in PBS containing 2 mM PMSF, incubated for 10 min at 90°C, and added to wells of 24-well cluster plates (Falcon, Bedford, MA). Plates were then incubated for 90 rain at 80°C. For studies involving nondenatured proteins, proteins were diluted to 10 p,g/ml in PBS containing 2 mM PMSF, added to wells, and plates were incubated at 20°C for 90 min. After this incubation, unbound protein was removed and unreacted sites were blocked with 1% protease-free BSA (Intergen Co., Purchase, NY) in PBS. In studies (not shown) using radiolabeled proteins, ~50% less protein bound to wells coated at 80°C than at 20°C. For some studies, wells were coated with 10 mg/ml BSA in PBS for 2 h at 37°C. Protein-coated wells were washed three times with PBS containing 0.2% BSA and incubated at 37°C with 106 cpm/ml 125I-labeled protein diluted in PBS with 0.2% BSA. Nonspecific binding was determined in separate wells by the addition of excess unlabeled protein to the binding medium. Specific binding was calculated by subtracting nonspecific binding from total binding.
Cell Binding Assays
1251-fibronectin binding assays were conducted as previously described (21) . Briefly, A1-F fibroblasts were seeded at 5 × 104 cells/well into 24-well cluster dishes (Falcon) in DMEM containing 10% FBS and allowed to grow to confluence for 3-4 d. Cells were washed three times with serumfree DMEM and incubated for 24 h with 0.5 x 106 cpm/ml 125I-fibronectin in DMEM containing 0.2% BSA in the absence or presence of either III-10, III-10A, or III-10A/RGE. After this incubation, unbound protein was removed, cells were washed with PBS, and bound protein was solubilized with 1 N NaOH. Nonspeciflc binding was determined by incubating the cells in the presence of excess unlabeled fibronectin (400 p~g/ml).
Immunofluorescence Microscopy
III-1,2 was diluted to 0.5 mg/ml in 0.05 M sodium borate buffer, pH 9.0, and directly conjugated to Texas red sulfonyl chloride (Molecular Probes, Eugene, OR) using N,N-dimethyl formamide, according to the manufacturer's protocol. The protein conjugate was separated from unreacted Texas red by gel filtration chromatography on G-25M Sephadex (Pharmacia). Protein concentration was determined from the absorbance at 280 nM.
18-mm glass coverslips were coated for 2 h at 37°C with 10 Ixg/ml of either fibronectin, the 160/180-kD fragment of fibronectin, the 111-9,10 modules of fibronectin, vitronectin, or laminin in PBS. Unbound protein was removed and A1-F fibroblasts were seeded onto coverslips in 12-well cluster dishes (Falcon) at 4 x 104 cells/well in DMEM containing 0.2% BSA.
To inhibit endogenous synthesis of fibronectin, cycloheximide was added at a concentration of 20 ixg/ml (23) . Cells were then incubated overnight at 37°C. After this incubation, 10 p,g/ml Texas red-labeled-llI-1,2 was added directly to the culture media and cells were incubated an additional 90 rain. In some studies, before the incubation with Texas red III-1,2, 50 p,g/ml of either 9D2, the monoclonal antibody clone 3E3 (31) (GIBCO BRL), or the monoclonal antibody LAB (a gift of Deane Mosher, University of Wisconsin, Madison, WI) were added directly to the culture medium. After a 1-h incubation, Texas red 11I-1,2 was added to the culture media and ceils were incubated an additional 90 min. The epitope recognized by the Lab monoclonal antibody is contained within the region 111-4 to 111-8 (5). The epitope recognized by the 3E3 monoclonal antibody is contained within the 15-kD cell-binding fragment of ftbronectin (31). Media was then removed and cells were fixed with 3.7% paraformaldehyde in Small's cytoskeletal buffer (41) and permeabilized with 0.5% Triton X-100. Cells were stained for 1~] integrins using the monoclonal anti-13 t antibody, AIIB2 (a gift of Caroline Damsky, University of California, San Francisco, CA), followed by incubation with a fluorescein-conjugated goat anti-rat antibody (Cappel) for 60 min. Cells were washed, mounted, and then examined using an Olympus microscope.
Results
Identification of a Binding Site within the Integrin-binding III-10 Module of Fibronectin for llI-1
Cellular adhesion to fibronectin is mediated primarily by the a5[~1 integrin, which binds to fibronectin via the ArgGly-Asp sequence contained within the III-10 module (16, 32, 34) . A role for the integrin in fibronectin matrix assembly has previously been demonstrated in studies in which addition of antibodies directed against the e~5[~ 1 integrin was shown to inhibit fibronectin polymerization and decrease 70 kD binding to cell surfaces (9) . Our previous study indicated that the III-1 module of fibronectin contains a conformation-dependent site which binds to the amino-terminal region of fibronectin with high affinity (15) . Based on these studies, we postulated that expression of 70 kD binding sites within the III-1 module may be regulated by an interaction between the III-1 and III-10 modules. To determine whether III-1 binds to III-10, solid phase binding studies were conducted using recombinant III-1 and III-10 modules. As shown in Fig. 2 A, 125I-III-1 bound to wells coated with heat-denatured III-10, whereas 125I-III-2 did not. In addition, l:SI-III-1 did not bind to III-10 which was not heat-denatured before its adsorption onto tissue culture plastic (Fig. 2 A) , suggesting that the binding site in the III-10 module for III-1 is conformation dependent. To determine whether III-1 bound selectively to heat-denatured III-10, the binding of t25I-III-1 to other heat-denatured modules was assessed. As shown in Fig. 2 B, both heat-denatured III-10 and heat-denatured III-5 supported higher levels of 125I-III-1 binding than did heat-denatured III-1 or heat-denatured III-2. These results indicate that III-1 can bind to heat-denatured III-10 and may also bind to other heat-denatured type III modules in solid phase binding assays. However, in additional experiments described in this study, we were unable to detect any functional significance for the interaction between III-1 and III-5.
Inhibition of Fibronectin Binding to Heat-denatured III-10 by III-1
To determine whether heat-denatured III-10 is able to recognize III-1 within the context of the intact fibronectin molecule, binding of radiolabeled fibronectin to heat- , and incubated for 60 min at 37°C with 0.5 × 10 6 cpm/ml of 125I-III-1. Plates were then rinsed, bound protein was solubilized in 1 N NaOH, and radioactivity was determined. Nonspecific binding was determined in separate wells by performing the assay in the presence of 25 ixg/ml unlabeled 111-1 or 111-2. Nonspecific binding, which was ~30% of total binding, was subtracted from total binding to determine specific binding. Data are presented as the amount of protein bound per well and represent one of three experiments performed in duplicate.
denatured III-10 was assessed in the presence of increasing concentrations of unlabeled III-1. Binding of 125I-labeled fibronectin to heat-denatured III-10 was inhibited in a dosedependent manner by 111-1 (Fig. 3) . In contrast, 111-2 had no effect on fibronectin binding to heat-denatured 111-10 ( Fig. 3) . In addition, 125I-fibronectin binding to heatdenatured III-10 was inhibited by the addition of the anti-III-1 monoclonal antibody 9D2 (data not shown). These data indicate that intact fibronectin can bind to conformationally altered III-10 and that this binding is dependent on the III-1 module.
Inhibition of lII-I Binding to Heat-denatured III-I0 by 9D2
Previous studies (5, 24, 25) have demonstrated a role for III-1 in self-interactive events thought to be involved in the polymerization of fibronectin on cell surfaces. In matrix assembly assays done on fibroblast monolayers, the anti-III-1 monoclonal antibody, 9D2, blocked the polymerization of fibronectin by fibroblasts at a step subse- were coated with 10 ~g/ml heat-denatured III-10, as indicated under Materials and Methods, and incubated for 60 min at 37°C with 0.5 × 106 cpm/ml of ]25I-fibronectin in the absence or presence of increasing concentrations of unlabeled III-1 (e) or 11I-2 (©). Plates were then rinsed, bound protein was solubilized in 1 N NaOH, and radioactivity was determined. Data represent one of three experiments performed in duplicate.
quent to the initial amino-terminal binding of fibronectin to the cells (5). The complementary site for III-1 binding was not identified. To determine whether 9D2 recognizes the III-10 binding site within the III-1 module, binding of 1251-111-1 to heat-denatured III-10 was assessed in the presence of increasing concentrations of either 9D2 or nonimmune mouse Fab' fragments. As shown in Fig. 4 A, 9D2 Fab' fragments inhibited 1251-111-1 binding to heat-denatured III-10 in a dose-dependent manner. A 50% inhibition of 1251-11I-1 binding to heat-denatured III-10 was obtained at a concentration of 1 #xg/ml 9D2 Fab' (Fig. 4 A) . This concentration of 9D2 is similar to that previously shown to cause a 50% inhibition of 125I-fibronectin binding to cell surfaces (5) . In contrast, nonimmune Fab' fragments had no effect on 1251-111-1 binding to heat-denatured III-10 (not shown). We previously reported that the III-1 module contains a conformation-dependent binding site for the amino-terminal 70-kD fibronectin fragment (15) . To test whether 9D2 inhibits the interaction of 70 kD with heat-denatured III-1, binding of 1251-70 kD to heat-denatured III-1 was assessed in the presence of increasing concentrations of 9D2 Fab' fragments. In contrast to the results described above (Fig.  4 A) , 9D2 Fab' fragments had no effect on the binding of ~251-70 kD to heat-denatured III-1 (Fig. 4 B) . The inability of 9D2 to block ]251-70 kD binding to heat-denatured III-1 was not due to an inability of 9D2 to recognize the conformationally altered form of III-1. In separate studies using an enzyme-linked immunoassay (8), 9D2 recognized III-1 and heat-denatured III-1 equally well (not shown).
Binding of Amino-Terminal Fragments to Heat-denatured IIl-lO in the Presence of IlV l,2
Solid phase binding assays were conducted to determine if a complex could be formed between heat-denatured III- Plates coated with heat-denatured III-1 (B) were incubated for 60 min at 37°C with 0.5 × 106 cpm/ml of ]251-70 kD (,~100 ng/ml), in the presence of increasing concentrations of 9D2 Fab' fragments. Plates were then rinsed, bound protein was solubilized in 1 N NaOH, and radioactivity was determined. Data represent one of three experiments performed in duplicate.
10, III-1, and the amino terminus of fibronectin. Tissue culture wells coated with heat-denatured III-10 were incubated with 125I-labeled 70 kD amino-terminal fragment of fibronectin in the absence or presence of either III-1,111-2, or III-1,2. Whereas 1251-70 kD itself did not bind to heatdenatured III-10 ( Fig. 5 A) , preincubation of heat-denatured III-10 with increasing concentrations of 111-1,2 resulted in a dose-dependent increase in 1251-70 kD binding (Fig. 5 A) . Similar results were obtained using the 1251-27-kD fragment (data not shown). In contrast, addition of III-1,2 to plates coated with heat-denatured Ill-5 did not promote 1251-70 kD binding (Fig. 5 A) . Neither III-1 nor Ill-2 alone could support the formation of this ternary complex on heat-denatured III-10 ( Fig. 5 A) . In parallel studies (not shown), the binding of 1251-111-1 to heat-denatured III-10 was greater than the binding of ]251-111-1,2 to heatdenatured III-10, indicating that the inability of III-1 to promote 1251-70 kD binding was not the result of decreased binding to heat-denatured III-10. These data suggest that the presence of II1-2 in the III-1,2 construct may stabilize 111-1 in the appropriate conformation to support the ternary complex formation. As shown in Fig. 5 B, 1251-27 kD binding to the III-1,2/II1-10 complex was dependent on the binding of 111-1 to heat-denatured 111-10, since addition of 9D2 Fab' fragments resulted in an inhibition of 1251-27 kD binding. Similar results were obtained using the 1251-70 kD fragment (data not shown). Taken together, these results indicate that a ternary complex can be formed in which III-1 simultaneously binds to both 111-10 and the amino terminus of fibronectin.
Formation of Fibronectin Multimers by Heat-denatured III-10
Upon binding to cells, fibronectin accumulates as high molecular mass aggregates which do not penetrate the stacking gel when analyzed by SDS-PAGE. These aggregates, which are thought to represent fibronectin in the extracellular matrix, can be dissociated to monomeric fibronectin with reducing agents (21). Morla et al. (25) have recently shown that in the absence of cells, a fibronectin construct containing two thirds of the III-1 module can induce the formation of fibronectin multimers. The authors speculate that the activity of their III-1 construct may be masked in the intact fibronectin molecule but may be exposed on the cell surface as a result of fibronectin binding to the a5131 integrin. To determine if the interaction of conformationally altered III-10 with III-1 within the intact fibronectin molecule could promote the formation of disulfide-stabilized high molecular mass fibronectin multimers, solid phase binding assays were conducted using assay wells coated with either heat-denatured III-10, heat-denatured III-1, nonheat-denatured III-10, or BSA. Incubation of IzsI-fibronectin in wells coated with either heat-denatured III-10 or heat-denatured III-1 resulted in specific fibronectin binding (Fig. 6 A) . Samples containing equal cpm were then analyzed by SDS-PAGE followed by autoradiography. Incubation of 125I-fibronectin with heat-denatured III-10 resulted in the formation of high molecular mass fibronectin aggregates which did not penetrate the stacking gel ( Fig. 6 B, arrow). To quantitate these aggregates, gel slices were removed and counted (Fig. 6 C) . In the presence of a reducing agent, no high molecular mass aggregates were detected ( Fig. 6 C) ; only monomeric subunits were present (Fig. 6  B) . In addition, the III-10 module must be conformationally altered in order to induce fibronectin multimer formation, since incubation of 125I-fibronectin with wells coated with III-10 which was not heat-denatured did not result in either specific fibronectin binding (Fig. 6 A) or multimer formation (Fig. 6 C) . Whereas 125I-fibronectin bound avidly to wells coated with heat-denatured III-1 (Fig. 6 A) , when analyzed by SDS-PAGE, no high molecular mass multimers were detected (Fig. 6 B, arrow and Fig. 6 C) .
The binding of fibronectin to heat-denatured III-1 was completely inhibited by the addition of excess amino-terminal 70-kD fragment (not shown), indicating that fibronectin binding to heat-denatured III-1 was dependent upon the amino-terminal region. Heat-denatured III-5, although capable of binding III-1 in solid phase assays (Fig.  2) , was not active in promoting disulfide-stabilized fibronectin multimers (data not shown).
Inhibition of lII-l O-induced Fibronectin Multimers with 9D2 or 27 kD
To test whether the III-1 module in intact fibronectin interacts with conformationally altered III-10 during the formation of fibronectin multimers, 125I-fibronectin was incubated in wells precoated with heat-denatured III-10, in the presence of increasing concentrations of 9D2 Fab' frag- __.
ments. Addition of 9D2 Fab' fragments resulted in a dosedependent decrease in fibronectin binding (Fig. 7 A) and a parallel decrease in multimer formation (not shown). In contrast, nonimmune Fab' fragments had no effect on 125I-fibronectin binding to heat-denatured III-10 ( Fig. 7 A) . Addition of either the 27-kD or 70-kD amino-terminal fibronectin fragment to cells blocks the polymerization of fibronectin on cell surfaces (22, 35) . To determine whether the formation of fibronectin multimers on conformationally altered III-10 also involves the amino-terminal region of fibronectin, 125I-fibronectin was incubated with wells precoated with heat-denatured III-10 in the presence of increasing concentrations of the 27-kD fibronectin fragment. Addition of 27 kD resulted in a dose-dependent decrease in fibronectin binding (Fig. 7 B) and a parallel decrease in multimer formation (not shown). In contrast, addition of the 40-kD gelatin-binding fibronectin fragment to the reaction had no effect (Fig. 7 B) . These data indicate that both III-1 and the amino terminus are involved in the formation of III-10-induced disulfide-stabilized fibronectin multimers. In addition, these data suggest that the intramolecular interactions involved in the polymerization of fibronectin on cell surfaces and in the formation of III-lO-induced fibronectin multimers are similar. 
A Fragment ofllI-lO Inhibits In Vitro Multimer Formation
An amino-terminal fragment of III-10 (III-10A), with an apparent molecular mass of 14.5 kD, was generated by digestion of the GST/III-10 fusion protein with trypsin. Amino acid sequencing of III-10 and III-10A yielded identical results, indicating that III-10A is generated by cleavage of carboxy-terminal residues from III-10. Whereas intact III-10 had no effect on the binding of 1251-111-1 to heat-denatured III-10, addition of III-10A to assay wells blocked the binding of 1251-111-1 to heat-denatured 111-10 (not shown), suggesting that the conformation-dependent binding site for III-1 is exposed in the III-10A fragment. Results from our studies with the 9D2 antibody indicate that the interaction of III-1 with the conformation-dependent site in 111-10 is involved in the formation of fibronectin multimers. To test whether III-10A could similarly inhibit the formation of III-10-induced fibronectin multimers, 125I-fibronectin was incubated in wells coated with heat-denatured III-10 in the presence of either intact III-10 or the III-10A fragment. Addition of III-10A resulted in a dose-dependent inhibition of binding of 125I-fibronectin to heat-denatured III-10 ( Fig. 7 C) and subsequent multimer formation (not shown). In contrast, intact 111-10 had no effect on 125I-fibronectin binding to heat-denatured III-10 ( Fig. 7 C) . These results suggest that the 111-1 binding site in III-10 is exposed by proteolytic removal of carboxy-terminal amino acids. Figure9. Immunofluorescent colocalizationoflII-1,2and131integrinsonfibroblasts. A1-Fs (4 × 104 in DMEM/0.2%BSA with 201xg/ml cycloheximide) were incubated for 18 h on coverslips coated with 10 p~g/ml of either fibronectin (a-c) or 160/180-kD fibronectin fragment (d-f). Cells were then stained with 10 p~g/ml Texas red-conjugated-III-1,2 (b and e) for 90 min at 37°C. Cells were fixed, permeabilized, and stained for 131 integrins using a monoclonal anti-131 antibody followed by an FITC-conjugated goat anti-rat Fab2 (a and d). The IRM image is shown in panels c and f. Arrowheads indicate colocalization of III-1,2 and 131 integrin staining at sites of focal contacts.
100-fold less than the concentration of the ll-kD cellbinding fragment needed to disrupt adhesion of cells to fibronectin (31). No change in 125I-fibronectin binding was observed with the addition of either 111-2 or intact III-10 to confluent cell monolayers (not shown).
Inhibition of Fibronectin Matrix Assembly by III-IOA
Previous studies have demonstrated that the addition of Arg-Gly-Asp peptides to cell monolayers disrupts the interaction of fibronectin with the ets131 integrin (32) and inhibits fibronectin matrix assembly (6) . To determine whether the effects of the III-10A fragment on matrix assembly were due to the disruption of fibronectin-integrin interactions, a recombinant III-10 fragment was produced in which the Arg-Gly-Asp sequence was mutated to Arg- Figure 10 . Localization of III-1,2 binding sites. A1-Fs (4 × l0 s in DMEM/0.2%BSA with 20 p~g/ml cycloheximide) were incubated for 18 h on coverslips coated with 10 Ixg/ml of Ill-9,10. Cells were then incubated with either media alone (panels a and d), 9D2 (panels b and e), or 3E3 (panels c and 3'). Cells were stained with 10 Ixg/ml Texas red-conjugated-Ill-I,2 (a-c) for 90 min at 37°C. Arrowheads indicate localization of III-1,2 at sites of focal contacts. The IRM image is shown in d, e, and f.
Gly-Glu (III-10A/RGE). The III-10A/RGE module was as effective as the nonmutant III-10A in inhibiting fibronectin binding to fibroblast monolayers (Fig. 8) , indicating that the inhibition of fibronectin matrix assembly by III-10A was not due to the disruption of fibronectin-ct5131 integrin interactions.
Colocalization oflii-1,2 with fll lntegrins
We postulated that upon binding of fibronectin to the as~ 1 integrin, a conformational change may occur in the III-10 module which serves to expose the III-1 binding site. If so, cell surface binding sites for exogenously added III-1 should colocalize with 131 integrins. To test this hypothesis, A1-F fibroblasts were seeded onto fibronectin-or 160/180 kD fragment-coated coverslips in the presence of cycloheximide and allowed to adhere and spread for 18 h. Cells were then incubated with Texas red-conjugated 111-1,2 for 90 min. The 111-1,2 construct was chosen for use in cell assays based on its ability to promote the ternary complex with 111-10 and the amino terminus of fibronectin (Fig. 5  A) . In addition, a 14-kD chymotryptic fragment, containing portions of both the first and second type III modules, has previously been shown to bind to cell surfaces and inhibit fibronectin assembly (24) . Cells were fixed, permeabilized, and stained for 131 integrins using a monoclonal anti-131 antibody followed by an FITC-conjugated secondary antibody. 111-1,2 and 131 integrins were colocalized on the same cell using epifluorescence microscopy. As shown in Fig. 9 , Texas red-conjugated 1II-1,2 staining (panels b and e) was detected on cells seeded onto either fibronectin (panels a-c) or the 160/180-kD fibronectin fragment (panels d-f). In contrast, II1-1,2 staining was not detected on cells which had been seeded onto either laminin or vitronectin (not shown). Moreover, Texas red--conjugated 111-1,2 staining was localized to regions of 131-integrin staining (Fig. 9, a  and b) , which occurred at areas of focal adhesions, as observed under IRM optics (Fig. 9, c and f) . Similar results were observed with cells seeded onto the 160/180-kD fragment of fibronectin (Fig. 9, d-f) , which does not contain the amino-terminal region, indicating that the 111-1,2 was not binding directly to the amino terminus.
Localization of Cell Surface 111-1,2 Binding Sites to III-10
To further localize cell surface III-1,2 binding sites, Texas red III-1,2 was incubated with A1-F fibroblasts which had been seeded overnight onto coverslips coated with a fibronectin construct containing the III-9 and III-10 modules (III-9,10). This construct contains the synergy site within the II1-9 module that is required for cell spreading (3, 29) . Binding sites for Texas red III-1,2 were observed on the surface of cells adherent to III-9,10 ( Fig. 10 a, arrowheads) . These sites also localized to focal adhesions, as observed under IRM optics (Fig. 10 d, arrowheads) .
1~5I-III-1,2, in the absence of cells, did not bind to coverslips coated with III-9,10 (not shown), indicating that the interaction of the cell with III-9,10 was required for the expression of III-1,2 binding sites. To localize III-1,2 binding to the III-10 module, cells adherent to III-9,10 were incubated with 50 txg/ml of either the anti-III-1 monoclonal antibody, 9D2, or the monoclonal antibody 3E3. Clone 3E3 has previously been shown to recognize the 15-kD cell-binding fragment of fibronectin (33) and recognizes the III-9,10 construct in Western blots (data not shown). After 1-h incubation, Texas red 111-1,2 was added directly to the culture media and cells were incubated an addi- (Fig. 10 b) or 3E3 (Fig. 10 c) completely inhibited the binding of 111-1,2 to cell surfaces. Inhibition of 11I-1,2 binding by the monoclonal antibodies was not due to disruption of cell adhesion, since sites of focal adhesions were observed in the presence of either 9D2 or 3E3 (Fig. 10, e and f, arrowheads) . These data suggest that the binding of III-1 to III-10 is required for the localization of 111-1,2 to the integrin/ 111-9,10 complex.
To determine if type III modules of fibronectin other than III-10 could serve as 111-1,2 binding sites on cell surfaces during the initiation of fibronectin polymerization, A1-F fibroblasts were plated onto coverslips coated with the 160/180-kD fragments of fibronectin and allowed to adhere and spread for 18 h. As previously shown (Fig. 9 b) , cells adherent to the 160/180-kD fragments of fibronectin expressed 111-1,2 binding sites on their surfaces (Fig. 11 a, arrowheads). Addition of either 3E3 (Fig. 11 b) or 9D2
(not shown) inhibited the expression of cell surface III-1,2 binding sites. In contrast, addition of the monoclonal antibody Lab, which recognizes an epitope within the region 111-4 to 111-8 (5), had no efffect on 111-1,2 binding site expression (Fig. 11 c) . Similar results were obtained with cells seeded onto intact fibronectin (not shown). Taken together, these data suggest that on cells newly adherent to protomeric fibronectin, the III-10 module serves as a cell surface binding site for III-1.
Discussion
We have recently reported that the amino terminus of fibronectin binds to a conformation-dependent site within the III-1 module of fibronectin (15) . In addition, the amino-terminal region of fibronectin was shown to bind to trypsinized cell surface fibronectin fragments which contained the 111-1 module (15) and to a recombinant fusion protein containing the first two type III repeats (1), suggesting that the interaction of the amino terminus with III-1 may be one of the homophilic interactions which occurs during the process of fibronectin matrix assembly. In the present study, we have defined a second homophilic interaction which may also function during the process of fibronectin polymerization. Our data indicate that the III-1 module also binds to a conformation-dependent site in the integrin-binding III-10 module. In addition, our data indicate that in the absence of cells, the interaction of III-1 in intact fibronectin with the conformation-dependent site in III-10 leads to the formation of high molecular mass fibronectin multimers through an interaction which involves the amino terminus. Taken together, our results suggest a mechanism whereby the interaction of III-10 with III-1 promotes a conformational change within the III-1 module which unmasks the amino-terminal binding site and triggers the self-polymerization of fibronectin.
A role for the cell-binding domain of fibronectin in matrix assembly was previously demonstrated in a study by McDonald et al. (20) , in which addition of either a 105-kD cell-binding fibronectin fragment or antibodies directed against this fragment inhibited matrix assembly. In addition, studies have demonstrated a role for lII-1 in fibronectin matrix assembly (5, 24) . The anti-III-1 monoclonal antibody, 9D2, has been shown to block the incorporation of exogenous fibronectin into the extracellular matrix (5) . In addition, a 14-kD fibronectin fragment, beginning 20 ° amino acid residues into the III-1 module, was shown to bind to both intact fibronectin and cell layers, and to block matrix assembly (24) . Neither the 9D2 antibody nor the 14-kD fragment inhibited the binding of the 70-kD fragment to cells (5, 24) . Similarly, in the present study, 9D2 had no effect on the ability of the 70-kD fragment to bind to II1-1. On the other hand, 9D2 was able to completely inhibit the interaction of III-1 with 111-10, at concentrations similar to those previously shown to block fibronectin polymerization on cell surfaces (5). It is possible, therefore, that one mechanism by which both 9D2 and the 14-kD fragment inhibit fibronectin polymerization on cell surfaces is by inhibiting the interaction of III-1 with III-10. In support of this is our observation that addition of the III-10 fragment (III-10A) to fibroblast monolayers also resulted in the inhibition of fibronectin polymerization. The ability of III-10A to inhibit fibronectin polymerization was not due to a disruption of cell adhesion, since the III-10A/ RGE construct, in which the integrin-binding RGD sequence was mutated to RGE (32), was also able to inhibit fibronectin polymerization. These results suggest that the III-10 module in fibronectin participates in a step in matrix assembly which is distinct from its integrin-binding activity.
Upon binding of the amino-terminal region to the cell surface, fibronectin accumulates in the extracellular matrix in the form of high molecular mass aggregates (21) . Cell-mediated fibronectin polymerization can be blocked by the addition of either amino-terminal fragments of fibronectin (22, 35) or the 9D2 antibody (5) . In the present study, the interaction of fibronectin with conformationaUy altered 111-10, in the absence of cells, resulted in the formation of disulfide-stabilized high molecular mass fibronectin multimers, via an interaction involving the aminoterminal region of fibronectin. Although earlier studies have demonstrated in vitro fibronectin multimer formation through either the oxidation of free sulfhydryls (27) , the use of reducing agents (46) , or the addition of metal ions (43) , the ability of both 9D2 and the 27-kD fibronectin fragment to inhibit III-10-induced fibronectin multimet formation suggests that the mechanisms involved in the formation of III-100induced multimers may be similar to those which mediate polymerization of fibronectin on cell surfaces. Morla et al. (25) have demonstrated that a fibronectin construct containing a portion of the III-1 module was able to induce fibronectin multimer formation by a mechanism which also involved the amino-terminal region of fibronectin. The authors suggested that the site in the III-1 construct which promotes multimer formation is cryptic within the III-1 module of intact fibronectin (25) .. In the present study, the ability of conformationally al-" tered III-10 to trigger fibronectin multimer formation involved both the 111-1 module and the amino terminus, suggesting that the cryptic site in III-1 may be unmasked upon its interaction with III-10. In addition, whereas binding of fibronectin to heat-denatured III-1 could be completely inhibited by the addition of excess amino-terminal 70-kD fragment, this interaction failed to trigger fibronectin multimer formation, suggesting that both the III-10 and aminoterminal binding sites in III-1 must be accessible during multimer formation.
On cell surfaces, fibronectin fibrils (36) and amino-terminal 70-kD fibronectin fragment binding sites (7) have been shown to colocalize with etsI31 integrins in focal adhesions. In addition, anti-[3~ integrin antibodies inhibit binding of the amino-terminal 70-kD fragment to the cell surface, suggesting that the ot5131 integrin can regulate the expression of amino-terminal binding sites (9) . One of the functions of integrins in matrix assembly, therefore, may be to provide adhesion sites in which fibronectin, bound to the integrin, undergoes a series of conformational changes resulting in the exposure of the amino-terminal binding site in III-1. In one of the initial steps of matrix assembly, binding of the III-10 module to the ot5131 integrin may directly alter the conformation of III-10 to expose the 111-1 binding site. To explore the role of asf31 integrins in the regulation of this conformation-dependent binding site within the III-10 module, we examined the expression of III-1 binding sites on cell surfaces. In the present study, cell surface binding sites for exogenously added 111-1,2 colocalized with [31 integrins at sites of focal adhesions on cells which had been plated onto fibronectin. In addition, 111-1,2 binding sites were expressed on cell surfaces following adhesion to the 111-9,10 modules. Moreover, monoclonal antibodies directed against either III-1 or the 15-kD cell-binding fragment blocked binding of II1-1,2 to cells plated onto either the II1-9,10 modules or the 160/180-kD fragments of fibronectin. Since the 160O80-kD fragments contain all of the fibronectin type III repeats, these data suggest that on cells adherent to protomeric fibronectin, the III-10 module serves as an initial cell surface binding site for III-1. The ability of HDIII-5 to support III-1 binding (Fig. 2 B) suggests that following the nucleation of fibronectin matrix assembly and the deposition of fibronectin into the extracellular matrix, other fibronectin type III modules may serve as additional matrix-derived binding sites for III-1, particularly during the lateral growth of a fiber. In the present study, which defines the initial steps involved in the initiation of fibronectin polymerization from protomeric fibronectin, the 3E3 monoclonal antibody was found to inhibit completely the cell surface expression of II1-1,2 sites on cells plated onto the 111-9,10 construct, the 160/180-kD fragments of fibronectin, and protomeric fibronectin. Taken together, these data are consistent with the hypothesis that binding of fibronectin to the etsI31 integrin regulates the unfolding of the III-10 module to expose the 111-1 binding site during the initial nucleation of fibronectin matrix assembly from cell surfaces.
Although several studies (2, 9, 11, 48) have implicated ets~ 1 integrins in the formation of fibronectin matrices, fi-broblastic cells derived from as-null embryos retain the ability to form focal contacts and assemble a fibronectin matrix, suggesting that other fibronectin receptors may substitute for the ctsl31 integrin during fibronectin polymerization (52) . The ability of other a subunits to substitute for a s in fibronectin matrix assembly has been examined using as-deficient CHO ceils. Expression of a4~1, which binds to the CS1 site located in the alternatively spliced IIICS region of fibronectin (10, 12, 45) , restored adhesion and spreading of as-deficient CHO cells on fibronectin, but did not restore the ability of these cells to assemble a fibronectin matrix, suggesting that direct binding of the integrin to the III-10 module may be necessary for the initiation of matrix assembly (49) . Expression of av131, which binds to the RGD site in the III-10 module of fibronectin (44) , restored the ability of as-deficient CHO cells to adhere to fibronectin, but did not restore their ability to assemble a fibronectin matrix (53) . In contrast to as131-expressing cells, avl3]-expressing cells demonstrated a lower affinity for fibronectin and did not localize avl3] to focal adhesions (53) . More recently, the activated form of a,ib[33 has been shown to promote fibronectin matrix assembly (50) . These data suggest that several components may be important in the initiation of matrix assembly, including the direct interaction of the integrin with the 111-10 module, the affinity of the integrin-fibronectin interaction, and the ability of the integrin-fibronectin complex to localize to focal adhesions.
In the present study, we have demonstrated that the III-10 module of fibronectin contains a conformationdependent binding site for the III-1 module and that the interaction of the III-1 module in intact fibronectin with the unfolded III-10 module promotes the generation of high molecular mass multimers through an interaction involving the amino-terminal region of fibronectin. Our data are consistent with a model in which de novo nucleation of fibronectin matrix assembly is initiated by sequential interactions involving the integrin and the 111-10 and III-1 modules of fibronectin. The interaction between III-10 and III-1 is blocked by the 9D2 monoclonal antibody. The inability of the 9D2 monoclonal antibody to inhibit either 70-kD binding to cell monolayers (5) or to heat-denatured III-1 (Fig. 4 B) suggests that the initial binding of the amino terminus of fibronectin to the cell surface is medi- Figure 12 . Model of III-1/III-10/integrin nucleation site. Schematic representation of fibronectin nucleation site in which the binding of the ct5131 integrin to the III-10 module in protomeric fibronectin exposes the III-1 binding site in III-10. Upon binding of a II1-1 module to the unfolded II1-10, the 70-kD binding site within the III-1 module is exposed, allowing the amino terminus of an incoming fibronectin molecule to be transferred to the III-1 module of the growing fibril. Addition of either 9D2 or III-10A inhibits the interaction of III-1 with III-10 and prevents the movement of 70 kD onto the nucleation complex.
ated by another molecule. Our model, depicted in Fig. 12 , predicts that once the III-10/III-1 complex is formed, the amino terminus is transferred from the binding site on the cell to the III-1 module. This model addresses the de novo nucleation of matrix asembly from cells adherent to protomeric fibronectin, and does not preclude the possibility that fibronectin polymerization may be initiated or propagated from other sites when cells are adherent to other matrix molecules.
The presence of an established fibronectin matrix may support the incorporation of dimeric fibronectin constructs lacking either the RGD sequence or the III-1 module (18, 40) . These studies did not distinguish between the ability of the fibronectin construct to bind to a preexisting fibronectin matrix and to actually undergo polymerization into fibrils. The studies presented here would suggest that such constructs would not undergo polymerization in the absence of a preexisting fibronectin matrix. In agreement with this, a dimeric construct containing only the aminoterminal 70-kD region and the carboxy-terminal bridge region of fibronectin has been shown to be incorporated into the extracellular matrix (42) . However, the dimeric 70-kD construct accumulated in the matrix of cycloheximidetreated cells only in the presence of intact fibronectin (42) . These data suggest that once the nucleation site is established, by either endogenous fibronectin or exogenously added fibronectin, subsequent interactions involving the unfolded III-1 module in the nucleation site, and the amino terminus of an incoming fibronectin molecule leads to the incorporation of the fibronectin molecule into the extracellular matrix. We propose that following initial adhesion of cells to protomeric fibronectin, nucleation of fibronectin matrix assembly occurs by an integrin-dependent unfolding of the III-10 domain which regulates the subsequent interaction between the unfolded III-10 module and the III-1 module of another fibronectin molecule. By controlling the interaction of III-10 with III-1, the 131 integrin thereby regulates the conformation of III-1, and, consequently, the polymerization of incoming fibronectin molecules into fibrils. Taken together, these data suggest that the nucleation of fibronectin polymerization proceeds by a series of sequential self-interactions which are regulated by the integrin-dependent unfolding of the III-10 module.
